University of Alabama Birmingham: Clinical Trial Will Test Possible COVID-19 Treatment for Outpatients
September 02, 2020
September 02, 2020
BIRMINGHAM, Alabama, Sept. 2 -- The University of Alabama Birmingham campus issued the following news:
Why is the COVID-19 virus more dangerous in people with comorbidities?
Sadis Matalon, Ph.D., of the University of Alabama at Birmingham and colleagues in Texas and San Francisco asked that question in a hypothesis paper (https://pubmed.ncbi.nlm.nih.gov/32216698/) published online in Physiological Reviews on March 27. They reviewed, in detail, research literature for co . . .
Why is the COVID-19 virus more dangerous in people with comorbidities?
Sadis Matalon, Ph.D., of the University of Alabama at Birmingham and colleagues in Texas and San Francisco asked that question in a hypothesis paper (https://pubmed.ncbi.nlm.nih.gov/32216698/) published online in Physiological Reviews on March 27. They reviewed, in detail, research literature for co . . .